Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics

Methotrexate (MTX) is a common first-line treatment for new-onset rheumatoid arthritis (RA). However, MTX is ineffective for 30–40% of patients and there is no way to know which patients might benefit. Here, we built statistical models based on serum lipid levels measured at two time-points (pre-tre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Maciejewski, Mateusz, Sands, Caroline, Nair, Nisha, Ling, Stephanie, Verstappen, Suzanne, Hyrich, Kimme, Barton, Anne, Ziemek, Daniel, Lewis, Matthew R., Plant, Darren
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012618/
https://ncbi.nlm.nih.gov/pubmed/33790392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86729-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia